Over 400 million individuals worldwide, according to the World Health Organization (WHO), have diabetes, living each day on the precipice of health determined by the level of sugar in their bloodstream. The vigilance required to ensure that their levels are neither too high nor too low can often become all-encompassing. A circumstance that Lonny Stormo, co-founder and CEO of the Oak Park Heights, Minnesota-based startup, Pops, truly understands.
Lonny Stormo, Co-founder and CEO of Pops
Stormo brought his proficiency in electrical engineering and business to the medical device industry over three decades ago. He has served in various executive leadership roles during his thirty-year career at industry giant Medtronic, and even collaborated with NASA. Though his work at Medtronic was primarily focused on cardiovascular health, he developed a vested interest in diabetes care when, in his mid-thirties, Stormo was diagnosed with adult onset type 1 diabetes.
As an active member of his community and an avid runner, Stormo was often frustrated by the encumbrance that conventional blood sugar monitoring would have on his lifestyle. After fifteen years of observing the same testing and tracking regimen, this medical device industry veteran began to question whether there was a better way to do this.
How can it be with all the advances we were making in medicine, that I had been managing my diabetes the same exact way these years, with the same black zip-up bag holding a meter and test strips and a lancing tool that you had to assemble, says Stormo, describing the equipment that those with diabetes typically use to keep track of their daily blood sugar levels, The test kit was too big to carry around wherever I went. Besides, I was not comfortable taking everything out to run a test in front of everybody and often there would not be a table around for me to set things up on. It was all very inconvenient.
Stormo suggested that because of the inconvenience associated with this cumbersome approach, many with diabetes, as he often did, would just leave their test kits at home. Beyond seeing their blood sugar level results perhaps, a couple times a day while at home, many do not have any idea what their true status is. That is, until the next biannual medical exam when the HbA1C test that indicates the prior months blood sugar level average, is performed. By then, if the readings suggest their blood sugar concentration has been too high, any deterioration to their health that could result may have already taken place.
Poor self-monitoring of blood sugar levels over time is a leading cause of long-term health complications for those with diabetes complications that range from nerve damage, vision loss, kidney failure, heart attacks, stroke and lower limb amputation to death. According to the most recent report from the International Diabetes Foundation (IDF) citing data for 2017, approximately four million deaths globally were attributed to known cases of diabetes, thus placing it among the top ten causes of mortality worldwide (WHO 2018). Associated healthcare costs, in 2017 alone, amounted to $727 billion USD globally of which 48% was attributed to individuals living in the United States. Americans with diabetes spent on average $12,000 USD on health care in 2017, which is twice the cost incurred by those who live without diabetes (numbers taken from IDF 2017 report).
Stormo recognized that the struggles he faced managing his own care reflected the experience of millions of others in the US and is implicated in the high health care costs for those with diabetes. So, he decided to do something about it.
He leveraged his decades of experience and extensive network in the medical device field to gather a team of like-minded colleagues co-founders, Dan Davis, Pops current Security Officer and VP of R&D, and Curt Christensen, Pops VP of Operations with a mission to improve the lives of those with diabetes. Thus, in 2015, Pops Diabetes Care was launched by this team that understands what living with diabetes is like, and who are determined to make it easier for those with diabetes to control their blood sugar levels, therefore reducing their risk of expensive health complications.
Our vision is lowering the worlds A1c one person at a time, Stormo explains.
Their strategy involves addressing the reasons why many individuals do not adhere to regular testing. A Reality of Diabetes Care Survey reported by the Canadian-based Medical Education Network (Mednet) back in 2010, identified several of these reasons thus validating what those dealing with these challenges daily have been saying for years. These reasons, further characterized in subsequent studies, include forgetfulness, insufficient time for regular testing, not having all the things needed to test, unreliable meters, not wanting to carry around the equipment for the tests, pain and testing anxiety, inability to test discretely, lack of motivation, and even concerns regarding safe disposal of the used test strips and lances. A daunting list of deterrents that Stormo and his team were all too familiar with.
If we want people to manage their diabetes all the time and do it better, says Stormo, We have to give them a better experience. What we have done is reengineered that experience to make it easy for them to test their blood sugar less painfully, discretely, no assembly needed, anywhere, at any time, with non-invasive, non-judgmental virtual coaching.
Stormo and his team developed a portable test kit that can (doesnt have to) pop-on to the back of a smartphone to which it interfaces via wireless connection to a Pops virtual management care app.
I can now literally check my blood sugar anytime, anywhere while I am on the road for a run, something I could never do before, explains an enthusiastic Stormo, One time at a business competition, I was standing on stage and it was time to check my blood sugar levels. So right there in front of hundreds of people, I quickly pulled out my phone and discretely did a test. Simple. No fuss.
The Pops approach aligns with the current shift in individual behavior being observed across the healthcare landscape. Subject to a conventional system that does not always serve their best interests, patients are less passively resigned to receive services offered as is. Rather they are being more selective about their care and are actively pursuing alternatives that confer better outcomes.
This increasing demand for consumer-focused healthcare services is further bolstered by the recent acceleration in technological innovation. In an imperfect healthcare system, where many struggle to access appropriate care, it is not surprising that individuals are seeking solutions through advanced technologies that enhance the delivery of such care.
A 2017 report by consulting group, Deloitte Development LLC, indicates that over 70% of consumers in the US prioritize access thus are comfortable using virtual health platforms to manage their own care or coordinate with providers. According to Statista, 77% of US adults surveyed over a two-month period in 2018 were satisfied with their virtual care experience, confirming this trend.
People want to take healthcare into their own hands using technology, says Stormo, Previously, we were using technology to connect patients and doctors, sending information to the doctor then waiting for the doctor to respond with what to do, perhaps via a video console. Now people are managing their health directly using easy, convenient, smart technology. And living their lives. This is the next step virtual care people are empowered to self-manage their conditions.
Pops not only includes an integrated virtual care system they call Rebel, but also Mina, a 24/7, non-judgmental personal virtual coach. Rebel and Mina together provide non-invasive blood sugar-testing and monitoring along with basic analytics that inform guidance and support. In addition, everyone using the system is considered an owner controlling how and with whom, if anyone, their information is shared, whether its with friends, family and/or caregivers.
At Pops, we are enabling you to take care of yourself, to own your condition, to own your life, says Stormo, You have diabetes, but it does not define you. You are a person first and foremost.
Last year, Pops patented system received FDA clearance. Since then, they have established partnerships with healthcare plans and employers who have included Pops in their employee benefits offerings, promoting healthier employees, greater productivity at work, and an associated reduction in company healthcare costs. In the future, Stormo would like for everyone with diabetes to have access to Pops, regardless. For now, the system is not yet directly available to the consumer.
This purpose-driven company has been gaining attention across the country. Pops recently closed an oversubscribed Series A funding round of $6 million USD as a result of heightened investor interest. The round was led by 30Ventures, a healthcare and biotechnology venture capital firm based out of Madison, Wisconsin.
Also participating in this round was New York-based investment firm, Flying Point Industries and Revolutions Rise of the Rest Seed Fund, a Washington D.C.-based firm founded by AOL co-founder Steve Case that focuses on funding highly promising seed stage companies outside the startup hubs of Silicon Valley, New York City, and Boston.
In a recent press release, Stormo expressed his gratitude for the strong investor support, We are pleased that investors see this commercial growth as a sign that diabetes virtual care is making a difference for people with diabetes. The funds will be used to further the commercialization of Pops system.
Pops was also recently chosen to participate in the 2019 Winter Insurtech program run by globally renowned startup accelerator, Plug and Play.
Though grateful for the validation and support received this year, for Stormo, nothing comes close to the fullfilment he experienced that memorable day, when Pops received the first testimonial from the first person whose HbA1C levels were lowered by 1.5 points using the Pops system.
The first thing we see each day walking through the front doors is his framed photo the first person whose life we changed, says Stormo proudly, That is what our mission is all about!
For more information about Lonny Stormo and Pops, visit http://www.popsdiabetes.com.
REFERENCES:
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
http://www.mednet.ca/docs/pdf/HO10-005_E_with_WM.pdf
Josh Nelson, Bryan Sung, Sunil Venkataram, and Jennifer Moore, Transforming care delivery through virtual health, Deloitte, 2017.
Read more here:
Pops on the go virtual care system empowers those with diabetes to Own Their Life - Silicon Prairie News
- Global report on diabetes - World Health Organization (WHO) - October 22nd, 2024
- Ultra-processed food may be particularly harmful for people with diabetes, scientists warn - The Independent - October 22nd, 2024
- New drugs may be able to treat multiple problems beyond diabetes - The Straits Times - October 22nd, 2024
- Best Fruits for Diabetes (and What To Avoid) - Health Essentials - October 22nd, 2024
- Cutting Sugar May Reduce Your Diabetes, Stroke, and Depression Risk - Healthline - October 22nd, 2024
- Can Diabetes Care Teams Improve Patient Outcomes and Value? - Medscape - October 22nd, 2024
- Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD - MD Magazine - October 22nd, 2024
- High expression of CNOT6L contributes to the negative development of type 2 diabetes - Nature.com - October 22nd, 2024
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic... - October 22nd, 2024
- Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway - Nature.com - October 22nd, 2024
- Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting - Beyond Type 1 - October 22nd, 2024
- COVID-19 linked to type 2 diabetes onset in children - Medical Xpress - October 22nd, 2024
- The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel... - October 22nd, 2024
- Does microdosing Ozempic work? What experts are saying about the diabetes drug also used for weight loss - Medical Xpress - October 22nd, 2024
- The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024 - Managed Healthcare Executive - October 22nd, 2024
- The overexpression of human amylin in pancreatic cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic... - October 22nd, 2024
- RNAO releases updated guidelines for diabetic foot ulcer care - Benefits and Pensions Monitor - October 22nd, 2024
- COVID-19 raises the risk of type 2 diabetes in children, study reveals - News-Medical.Net - October 22nd, 2024
- Semaglutide: What impact does it really have on heart health? - Medical News Today - October 22nd, 2024
- Glucose monitors for diabetes have finally been funded but a chronic workforce shortage will limit the benefits - The Conversation - October 22nd, 2024
- Early vs Late Fast Window: Is One More Effective? - Medscape - September 13th, 2024
- Breakthrough T1D Walk to Cure Type 1 Diabetes - KATU - September 13th, 2024
- Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed - Newsweek - September 13th, 2024
- Beds and Herts patients to be re-tested in diabetes results error - BBC.com - September 13th, 2024
- This common habit increases your diabetes risk by 50%; Heres how to fix it - The Economic Times - September 13th, 2024
- Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria - BMC Public Health - September 13th, 2024
- Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children - The Guardian - September 13th, 2024
- Could the Norton research teams studying diabetes and Alzheimer's come up with a cure? - Courier Journal - September 13th, 2024
- Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide - Healio - September 13th, 2024
- Study finds weekly insulin injections as effective for diabetes as daily shots - UPI News - September 13th, 2024
- Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says - The Conversation - September 13th, 2024
- With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes - PR Newswire - September 13th, 2024
- Dining with Diabetes workshops offered - The Courier-Express - September 13th, 2024
- Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing - News-Medical.Net - September 13th, 2024
- The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk - The... - September 13th, 2024
- Artificial pancreas shows promise in people with type 1 diabetes on kidney dialysis - MSN - September 13th, 2024
- How an Indian executive battled flesh-eating disease and diabetes, and won - South China Morning Post - September 13th, 2024
- India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence - PR Newswire - September 13th, 2024
- Why this diabetes drug may be the answer to NASA search for radiation protection - Texas Public Radio - September 13th, 2024
- The National Association of Chain Drug Stores and the American Diabetes Association Promote Nutrition Security and its Role in Preventing and Managing... - September 13th, 2024
- He took up running rather than take diabetes medication. It worked - South China Morning Post - March 18th, 2024
- Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for cosmetic reasons instead of for diabetes and obesity - Fortune - January 9th, 2024
- Transforming Corporate Health: Fitterfly's Success in Tackling Diabetes and Weight Issues - Business Standard - January 9th, 2024
- For Those With Diabetes On Medicare Part D, Insulin Is $35...If Its Covered - Forbes - October 27th, 2023
- Biologist Douglas Melton: I was studying frogs until my son was diagnosed with diabetes then I started looking for a cure - EL PAS USA - October 27th, 2023
- Diabetes and Hearing Loss with Concept by Iowa Hearing | Paid Content - Local 5 - weareiowa.com - May 9th, 2023
- COUNTY COLUMN: Learn to Live well with diabetes at The Well - Norman Transcript - May 1st, 2023
- Want to Cut Type 2 Diabetes Risk? This High-fat Food Can Be the Answer, According to New Study - Revyuh - May 1st, 2023
- Diabetes: What It Is, Causes, Symptoms, Treatment & Types - March 13th, 2023
- A number of healthtech startups claim they can reverse Type 2 diabetes. But caveats apply, caution doctors - Economic Times - March 13th, 2023
- Tampa doctor who lost brother to diabetes calls insulin price cut a 'game changer' - ABC Action News Tampa Bay - March 5th, 2023
- New study suggest people previously infected with COVID-19 could have increased risk for diabetes - CBS Los Angeles - February 16th, 2023
- Diabetes Symptoms, Causes, & Treatment | ADA - October 15th, 2022
- A nutritionist with type 1 diabetes shares the top 5 'food swaps' she eats to manage her blood sugar - CNBC - October 15th, 2022
- Diabetes and the gut: How a bacterial protein may impact insulin - Medical News Today - October 15th, 2022
- Milton teen involved in launch of diabetes support program - Milton Daily Standard - October 15th, 2022
- Providers Now Have Free Access to Latest Diabetes Technology in One Place - PR Newswire - October 15th, 2022
- 5 Modifiable Factors in Women with History of Gestational Diabetes Mellitus That Can Reduce the Risk of T2D - Pharmacy Times - October 15th, 2022
- BCMH the stoy of Diabetes and Determination - 921News - October 15th, 2022
- Can skipping a meal lead to diabetes and fat around abdomen? - The Indian Express - October 15th, 2022
- Type 2 Diabetes Drugs Market Research Report by Drug, Application, Distribution, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 -... - October 15th, 2022
- Diabetes: Symptoms, risks, and prevention - Wilmington News Journal, OH - July 17th, 2022
- Diabetes symptoms: The sign of nerve damage that often strikes at night - severe - Express - July 17th, 2022
- Local Teen Brings Smiles and Health Kits to Kids with Diabetes - River Journal Staff - July 17th, 2022
- Type 3 diabetes: symptoms, causes and treatments - Livescience.com - July 17th, 2022
- Diabetes Travel Essentials and Tips for the Approximately 21 Million Americans that Must Manage Their Diabetes While on Vacation - PR Newswire - July 17th, 2022
- A type of 'step therapy' is an effective strategy for diabetic eye disease - National Institutes of Health (.gov) - July 17th, 2022
- Diabetes education: one in five search results for diabetes lack reliable information - Open Access Government - July 17th, 2022
- Arch City Kids Theater Troupe Fights Type 1 Diabetes With Its Annual Revue - Broadway World - July 17th, 2022
- Nutrigenomics Testing Industry Forecast to 2027 - Insights Into Obesity, Diabetes, Cancer, and Cardiovascular Disease Applications -... - July 17th, 2022
- Harvard Scientists Have Developed a Revolutionary New Treatment for Diabetes - SciTechDaily - June 16th, 2022
- Do Viruses and Coxsackievirus Cause Type 1 Diabetes? - Healthline - June 16th, 2022
- Diabetes Week: Types 1 and 2 symptoms, causes and prevention - Yahoo Entertainment - June 16th, 2022
- Diabetes And Sex: Have Safe Sex While Managing Diabetes - MadameNoire - June 16th, 2022
- Diabetes Devices Market to Expand at the CAGR of 6.4% from 2019 to 2027, Increase in Prevalence of Diabetes Expected to Drive Global Market - BioSpace - June 16th, 2022
- Anemia and Diabetes: What You Should Know - Healthline - June 16th, 2022
- Patient Knowledge of Diabetes and CKD in an Inner-City Population - DocWire News - June 16th, 2022
- ASCENSIA DIABETES CARE ANNOUNCES EUROPEAN APPROVAL OF THE NEXT-GENERATION EVERSENSE E3 CONTINUOUS GLUCOSE MONITORING SYSTEM - PR Newswire - June 16th, 2022
- Understanding the Link between Diabetes Care and Sickle Cell Disease | NIDDK - National Institute of Diabetes and Digestive and Kidney Diseases... - June 16th, 2022
- Child type 2 diabetes referrals in England and Wales jump 50% amid obesity crisis - The Guardian - June 16th, 2022